Skip to main content

Plaintiffs Allege J&J Talc For Ovarian Cancer

Plaintiffs Allege J&J Talc For Ovarian Cancer

Plaintiffs Allege J&J Talc For Ovarian Cancer

Introduction

In a recent complaint filed by a couple, talcum powder has been alleged to cause ovarian cancer, which led to hysterectomy and multiple surgeries.

According to the lawsuit, the woman was diagnosed with ovarian cancer in August 2016, which was allegedly caused due to years of exposure to talcum powder products. She underwent pelvic lymphadenectomy, radical abdominal hysterectomy, and paraaortic lymph node biopsy, as well as a bilateral salpingo-oophorectomy, where both ovaries and fallopian tubes were removed.

Nearly 12,000 Johnson’s Baby Powder lawsuits and Shower-to-Shower lawsuits are pending in courts nationwide, claiming that the manufacturer failed to warn about the risks of using talcum powder. Last month, a California jury awarded $29 million to a woman with cancer who used J&J talc. In addition, last year a Missouri jury returned a landmark $4.7 billion verdict for 22 women diagnosed with ovarian cancer. Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. overlooks J&J's talcum powder multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) in the District of New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!